关注
Thomas E. Whittaker
Thomas E. Whittaker
Postdoctoral Researcher, Institute of Child Health, University College London
在 ucl.ac.uk 的电子邮件经过验证
标题
引用次数
引用次数
年份
Material cues as potent regulators of epigenetics and stem cell function
SW Crowder, V Leonardo, T Whittaker, P Papathanasiou, MM Stevens
Cell stem cell 18 (1), 39-52, 2016
2432016
Extracellular vesicles for tissue repair and regeneration: Evidence, challenges and opportunities
A Nagelkerke, M Ojansivu, L van der Koog, TE Whittaker, EM Cunnane, ...
Advanced drug delivery reviews 175, 113775, 2021
992021
Glycosaminoglycan-based biomaterials for growth factor and cytokine delivery: Making the right choices
D Hachim, TE Whittaker, H Kim, MM Stevens
Journal of controlled release 313, 131-147, 2019
982019
Experimental artefacts can lead to misattribution of bioactivity from soluble mesenchymal stem cell paracrine factors to extracellular vesicles
TE Whittaker, A Nagelkerke, V Nele, U Kauscher, MM Stevens
Journal of extracellular vesicles 9 (1), 1807674, 2020
752020
Genomic investigations of unexplained acute hepatitis in children
S Morfopoulou, S Buddle, OE Torres Montaguth, L Atkinson, ...
Nature 617 (7961), 564-573, 2023
722023
Co-evolution of quaternary organization and novel RNA tertiary interactions revealed in the crystal structure of a bacterial protein–RNA toxin–antitoxin system
F Rao, FL Short, JE Voss, TR Blower, AL Orme, TE Whittaker, BF Luisi, ...
Nucleic Acids Research 43 (19), 9529-9540, 2015
272015
Genomic investigations of acute hepatitis of unknown aetiology in children
S Morfopoulou, S Buddle, OE Torres Montaguth, L Atkinson, ...
MedRxiv, 2022.07. 28.22277963, 2022
252022
Molecular imaging of extracellular vesicles in vitro via Raman metabolic labelling
CC Horgan, A Nagelkerke, TE Whittaker, V Nele, L Massi, U Kauscher, ...
Journal of Materials Chemistry B 8 (20), 4447-4459, 2020
252020
Nanoscale molecular quantification of stem cell–hydrogel interactions
SA Maynard, A Gelmi, SC Skaalure, IJ Pence, C Lee-Reeves, JE Sero, ...
ACS nano 14 (12), 17321-17332, 2020
222020
Highly purified extracellular vesicles from human cardiomyocytes demonstrate preferential uptake by human endothelial cells
L Zwi-Dantsis, CW Winter, U Kauscher, A Ferrini, B Wang, TE Whittaker, ...
Nanoscale 12 (38), 19844-19854, 2020
202020
Versailles project on advanced materials and standards (VAMAS) interlaboratory study on measuring the number concentration of colloidal gold nanoparticles
C Minelli, M Wywijas, D Bartczak, S Cuello-Nuñez, HG Infante, J Deumer, ...
Nanoscale 14 (12), 4690-4704, 2022
182022
Gold nanocluster extracellular vesicle supraparticles: self-assembled nanostructures for three-dimensional uptake visualization
U Kauscher, J Penders, A Nagelkerke, MN Holme, V Nele, L Massi, ...
Langmuir 36 (14), 3912-3923, 2020
142020
Genome editing with TALEN, CRISPR-Cas9 and CRISPR-Cas12a in combination with AAV6 homology donor restores T cell function for XLP
BC Houghton, N Panchal, SA Haas, KO Chmielewski, M Hildenbeutel, ...
Frontiers in Genome Editing 4, 828489, 2022
92022
Cobalt containing glass fibres and their synergistic effect on the HIF-1 pathway for wound healing applications
AK Solanki, H Autefage, AR Rodriguez, S Agarwal, J Penide, M Mahat, ...
Frontiers in bioengineering and biotechnology 11, 1125060, 2023
72023
Extracellular vesicles as a promising source of lipid biomarkers for breast cancer detection in blood plasma
E Dorado, ML Doria, A Nagelkerke, JS McKenzie, S Maneta‐Stavrakaki, ...
Journal of extracellular vesicles 13 (3), e12419, 2024
12024
Multidimensional Response Surface Methodology for the Development of a Gene Editing Protocol for p67phox-Deficient Chronic Granulomatous Disease
TE Whittaker, SE Moula, S Bahal, FG Bakri, WA Hayajneh, AK Daoud, ...
Human Gene Therapy, 2024
12024
Preclinical Safety and Feasibility Study of a CRISPR/Cas9 Gene Editing Platform to Treat Wiskott Aldrich Syndrome
A Naseem, R Rai, G Turchiano, T Whittaker, AJ Thrasher, A Cavazza
MOLECULAR THERAPY 30 (4), 34-34, 2022
12022
Preclinical studies for a hematopoietic stem cell gene editing platform to treat Wiskott-Aldrich Syndrome.
A Naseem, W Vetharoy, R Rai, TE Whittaker, G Turchiano, AJ Thrasher, ...
HUMAN GENE THERAPY 32 (19-20), A72-A72, 2021
12021
Hematopoietic stem cell gene editing rescues B-cell development in X-linked agammaglobulinemia
S Bahal, M Zinicola, SE Moula, TE Whittaker, A Schejtman, A Naseem, ...
Journal of Allergy and Clinical Immunology, 2024
2024
Myelodysplasia and transgene inactivation in X-CGD-γ retroviral gene therapy: The usual suspects and new players
TE Whittaker, G Santilli
Molecular Therapy 31 (12), 3367-3368, 2023
2023
系统目前无法执行此操作,请稍后再试。
文章 1–20